Our Capabilities - Genovior Biotech Corporation

●	2015	Analytical/ Formulation/ Bio Process Development/ Synthesis Lab Q4 2015
●	2016	Microbial Pilot Plant ,5L~300L Aseptic Injectable Pilot Plant , 4000 Vials/ Batch
●	2017	Aseptic Injectable Plant , 40,000 Vials/ Batch Dedicated Oncology API & Lyophilization Vial Plant , 40,000 Vials/ Batch Peptide Pilot Plant
●	2018	Cartridge Pen Injectable Line,2,000 Pen/Hour Pre-Filled Syringe Line ,>10,000 PFS/Hour
●	2019	Microbial Commercial Plant, 3,000LX2 (Under Construction) Animal Cell Production Pilot Plant Animal Cell Production Commercial Plant (Monoclonal Antibody Drugs)

Genovior is in progress of building world class facilities that fully comply with the regulations of FDA, EMA and other agencies. The factories are equipped with state-of-art equipment which can furnish a total solutions for any of your projects: from process development of synthesis, microbial fermentation, purification, lyophilization and slow-release formulation, from piloting production to commercial contract manufacturing of either API or aseptic injectable.

* Dedicated facility

Our facilities are located in Northern and Southern of Taiwan, details could be found from below